Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic...
Fuchs Endothelial Corneal Dystrophy (FECD) Phase 1 Trial Initiated with Data Expected in the First Half of 2025 Friedreich Ataxia (FA) Program on Track to Initiate Phase 1 Single Ascending Dose...
CARLSBAD, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today...
Friedreich Ataxia (FA) and Fuchs Endothelial Corneal Dystrophy (FECD) Programs on Track and Advancing Toward Clinical Trials Active Research Pipeline with Programs Progressing in Myotonic...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.145 | 2.3751023751 | 6.105 | 6.45 | 5.16 | 270186 | 6.01331725 | CS |
| 4 | 0.69 | 12.4100719424 | 5.56 | 7.05 | 5.16 | 186355 | 6.21949572 | CS |
| 12 | 0.76 | 13.8433515483 | 5.49 | 7.77 | 4.485 | 168361 | 5.85073822 | CS |
| 26 | 2.68 | 75.0700280112 | 3.57 | 7.77 | 3.15 | 216340 | 5.22315561 | CS |
| 52 | 3.61 | 136.742424242 | 2.64 | 7.77 | 2.245 | 236601 | 4.23723167 | CS |
| 156 | -9.74 | -60.9130706692 | 15.99 | 26.3 | 1.94 | 346322 | 7.00130852 | CS |
| 260 | -21.75 | -77.6785714286 | 28 | 50 | 1.94 | 307909 | 8.44548504 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
